Foundation of the NLA
Dedicated to improving the welfare of patients and families affected by cholesterol and triglyceride problems.
@jama.com
JAMA is an international peer-reviewed general medical journal and a member of the JAMA Network family of journals. JAMA.com
@thebhf.bsky.social
We fund vital research into heart diseases, stroke and vascular dementia, and their risk factors like diabetes.
@familyheartfdn.bsky.social
The Family Heart Foundation is a patient-driven nonprofit focused on advocacy, research and education of FH and elevated Lipoprotein(a). Learn more: www.FamilyHeart.org #KnowFH #KnowLpa
@lipidjournal.bsky.social
The Journal of Clinical Lipidology is a leading peer-review journal covering a broad-array of topics within the clinical lipidology. @nationallipid.bsky.social
@drlipid.bsky.social
Longtime Lipid/Lipoprotein Educator with an extensive resume including Associate Editor of Journal of Clinical Lipidology. Practiced in NJ for 37 years. Has done 4000 lectures in all 50 states & authored many publications. Has two major awards from NLA
@daniellebelardomd.bsky.social
Cardiologist focused on prevention, lipids, cardiometabolic health, weight loss & nutrition #cardiosky
@drplantel.bsky.social
👩🏽⚕️Obesity, Lipid, Menopause, Culinary & IM Doc ✨Cardiometabolic health ⭐️Neuroscience nerd ⭐️Plant forward 🌟Physician burnout advocate 🚫 medical advice
@drnadolsky.bsky.social
Obesity and lipid specialist physician. Founder of Vineyard. Co-host of Docs Who Lift Podcast
@dineshkalra.bsky.social
Imaging & preventive cardiologist, Chief UofL Cardiology, Louisville
@stncsn.bsky.social
Molecular biology, nanopore sequencing and a pinch of bioinformatics. Genomics enthusiast. Lipoprotein(a) genetics and other strange DNA stuff. Assoc Prof at Med Univ Innsbruck, Austria. https://genepi.i-med.ac.at/team/coassin-stefan/
@rxpdx.bsky.social
PharmD/MedDir - CV Medical Affairs - Heart Failure and Lp(a). Thoughts and shares are my own and not endorsed by my employer Novartis #Portland #Maker #Dad
@cvia-journal.org
CVIA is a leading international journal focused on advancing cardiovascular health. We publish cutting-edge research on novel treatments, prevention strategies, and rehabilitation techniques for cardiovascular diseases.
@erinmichos.bsky.social
Cardiologist 🫀 & Researcher (women's health & CVD prevention). Professor at Johns Hopkins School of Medicine. Mother of a teenager. Loves travel ✈️, Barre classes, running 🏃♀️, & coffee ☕️ . She/hers
@jantonioglopezmd.bsky.social
Preventive Cardiologist and Lipidologist *The postings on this site are my own and do not represent Amgen’s positions, strategies, or opinions.*
@newamsterdampharma.bsky.social
NewAmsterdam Pharma Corporation is a late-stage clinical biopharma company developing therapies for cardiometabolic diseases. Intended for US audiences only. https://newamsterdampharma.com
@aagarwalamd.bsky.social
Director of #CVPrev #CardioOB @bswhealth.bsky.social @heart Plano | Training: @WustlCardFellow @BCM_internalmed @utswnews
@agyftomd.bsky.social
Chief Cardiology Fellow @UMMC, interested in preventive cardiology, lipidology, and medical education
@hsbhatia.bsky.social
Preventive Cardiologist and Epidemiologist @ucsdhealthsci.bsky.social | APD for Cardiology Fellowship | Editorial Board @ajpcardio.bsky.social, ATVB, EJPC | LA sports #CardioSky
@nationallipid.bsky.social
A non-profit, multi-disciplinary medical society focused on enhancing the practice of lipid management in clinical medicine. @lipidjournal.bsky.social #NLA #Lipids
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: [email protected]